NCT00243074 2018-01-23
S0509 - AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By Surgery
National Cancer Institute (NCI)
Phase 2 Completed
Clinical Trials
5 trialsNCT00309946 2014-07-31
Cediranib Maleate in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By Surgery
National Cancer Institute (NCI)
Phase 2 Completed
NCT00502567 2011-07-27
A Study to Assess Safety, Tolerability and PK of AZD2171 and Chemotherapy on Patients With Solid Tumors
AstraZeneca
Phase 1 Completed
NCT00501605 2011-01-21
Phase I Study With AZD2171 in Patients With Advanced Solid Malignant Tumors and Liver Metastases
AstraZeneca
Phase 1 Completed
NCT00503477 2009-06-12
A Phase I Open Label Dose Escalation Study for the Safety and Tolerability of AZD2171 in Solid Tumors in Japan
AstraZeneca
Phase 1 Completed